"10.1371_journal.pone.0051972","plos one","2012-12-27T00:00:00Z","Louise Knudsen; Bo Falck Hansen; Pia Jensen; Thomas Åskov Pedersen; Kirsten Vestergaard; Lauge Schäffer; Blagoy Blagoev; Martin B Oleksiewicz; Vladislav V Kiselyov; Pierre De Meyts","Receptor Systems Biology Laboratory, Hagedorn Research Institute, Gentofte, Denmark; Department of Insulin and Incretin Biology, Hagedorn Research Institute, Gentofte, Denmark; Insulin Biology, Novo Nordisk A/S, Måløv, Denmark; Biochemistry and Molecular Biology, University of Southern Denmark, Odense M, Denmark; Arsanis Biosciences, Vienna, Austria","Conceived and designed the experiments: LK PDM MBO LS. Performed the experiments: LK BFH PJ TÅP KV. Analyzed the data: LK BFH LS PDM MBO TÅP VVK. Contributed reagents/materials/analysis tools: LS BB. Wrote the paper: LK MBO PDM VVK. Discussing of data and proofreading of the manuscript: LK BFH PJ TÅP KV LS BB MBO VVK PDM.","The authors have read the journals policy and have the following conflicts: Thomas Åskov Pedersen, Kirsten Vestergaard, Pierre De Meyts, Vladislav V. Kiselyov, Bo Falck Hansen, Pia Jensen, and Lauge Schäffer were employees of Novo Nordisk A/S. Pierre De Meyts, Bo Falck Hansen, Pia Jensen, Lauge Schäffer Louise Knudsen, Kirsten Vestergaard and Thomas Åskov Pedersen own Novo Nordisk stocks. Novo Nordisk were a funder for this study and provided the S661 and S961 for the study. Martin B. Oleksiewicz was employed by Arsanis Biosciences at the time of the study. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Louise Knudsen","LK",10,TRUE,4,5,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
